Cone Edward J, Buchhalter August R, Lindhardt Karsten, Elhauge Torben, Dayno Jeffrey M
a PinneyAssociates , Bethesda , MD , USA.
b Egalet Corporation , Wayne , PA , USA.
Am J Drug Alcohol Abuse. 2017 May;43(3):291-298. doi: 10.1080/00952990.2016.1278006. Epub 2017 Feb 13.
US FDA guidance recommends measuring the degree of effort needed to manipulate abuse-deterrent (AD) opioids. The ALERRT instrument (PinneyAssociates; Bethesda, MD) uses visual analog scales to assess the labor, effort, and resources necessary to physically compromise AD product candidates in standardized settings.
Use the ALERRT instrument for testing morphine abuse-deterrent, extended-release, injection-molded tablets (ADER-IMT) 60 and 100 mg and the comparators immediate-release (IR) morphine sulfate 30 mg and extended-release (ER) morphine sulfate 60 mg.
Four technicians tested the products using 10 household tools. The ALERRT instrument quantified effort (all tools) and time (3 preselected tools) required for manipulation.
Morphine-ADER-IMT 60 and 100 mg were difficult to manipulate, as demonstrated by high scores (mean range, 71.0-99.0 and 77.0-99.5, respectively). IR and ER morphine sulfate were easy to manipulate (low scores; mean range, 2.0-14.8 and 2.3-17.5, respectively). Statistically significant mean differences between morphine-ADER-IMT and comparators' ALERRT scores were observed. Manipulations of morphine-ADER-IMT 60 and 100 mg for 300 seconds failed to produce substantial powdering. Manipulations of IR morphine sulfate (mean range, 65.5-175.8 seconds) and ER morphine sulfate (49.3-163.0 seconds) produced substantial to complete powdering in 92% of tablets.
Morphine-ADER-IMT was extremely difficult to manipulate versus non-AD formulations of morphine. The ALERRT system differentiated the degree of effort for manipulation of morphine-ADER-IMT and non-AD morphine formulations, indicating sensitivity of this instrument as part of Category 1 testing. By measuring the degree of effort required for manipulation, the ALERRT instrument provides an empirical assessment into the relative difficulty of manipulating opioid analgesics for abuse.
美国食品药品监督管理局(FDA)指南建议测量操控阿片类药物滥用威慑(AD)制剂所需的努力程度。ALERRT仪器(PinneyAssociates公司;马里兰州贝塞斯达)使用视觉模拟量表来评估在标准化环境中对AD候选产品进行物理破坏所需的劳动、努力和资源。
使用ALERRT仪器测试60毫克和100毫克的吗啡滥用威慑缓释注射成型片(ADER-IMT)以及对照品30毫克即释硫酸吗啡和60毫克缓释硫酸吗啡。
四名技术人员使用10种家用工具对产品进行测试。ALERRT仪器对操作所需的努力程度(所有工具)和时间(3种预先选定的工具)进行量化。
60毫克和100毫克的吗啡-ADER-IMT难以操控,高分显示了这一点(平均范围分别为71.0 - 99.0和77.0 - 99.5)。即释和缓释硫酸吗啡易于操控(分数低;平均范围分别为2.0 - 14.8和2.3 - 17.5)。观察到吗啡-ADER-IMT与对照品的ALERRT分数之间存在统计学上显著的平均差异。对60毫克和100毫克的吗啡-ADER-IMT进行300秒的操作未能产生大量粉末。即释硫酸吗啡(平均范围为65.5 - 175.8秒)和缓释硫酸吗啡(49.3 - 163.0秒)的操作在92%的片剂中产生了大量至完全粉末化。
与非AD吗啡制剂相比,吗啡-ADER-IMT极难操控。ALERRT系统区分了操控吗啡-ADER-IMT和非AD吗啡制剂所需的努力程度,表明该仪器作为1类测试的一部分具有敏感性。通过测量操作所需的努力程度,ALERRT仪器对操控阿片类镇痛药用于滥用的相对难度提供了实证评估。